SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001562762-24-000112
Filing Date
2024-04-29
Accepted
2024-04-29 17:06:35
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A vaxxq410k.htm   iXBRL 10-K/A 540021
2 EX-31.3 exhibit313.htm EX-31.3 4246
3 EX-31.4 exhibit314.htm EX-31.4 4254
  Complete submission text file 0001562762-24-000112.txt   827445

Data Files

Seq Description Document Type Size
4 EX-101.SCH vaxx-20231231.xsd EX-101.SCH 1848
5 EX-101.LAB vaxx-20231231_lab.xml EX-101.LAB 31478
6 EX-101.PRE vaxx-20231231_pre.xml EX-101.PRE 18925
19 EXTRACTED XBRL INSTANCE DOCUMENT vaxxq410k_htm.xml XML 7756
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41058 | Film No.: 24892486
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)